News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ismail Abdul Fattah Agrees to Become CytoDyn's Senior Advisor of Business Development for the Middle East



1/19/2012 6:25:30 AM

LUTZ, Fla.--(BUSINESS WIRE)--CytoDyn Inc. (the "Company") (OTC QB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, and other antibody applications, announced today that Ismail Abdul Fattah will serve as the Company's Senior Advisor of Business Development for the Middle East. Mr. Fattah will continue to serve in his role with AM Financials s.a.l, in Beirut, Lebanon. As part of the Company's evolution and international business development activities, Mr. Fattah will work in conjunction with Dr. Nadar Pourhassan, the Company's Managing Director of Business Development, to expand the Company's business development activities in the Middle East.

Read at BioSpace.com


comments powered by Disqus
CytoDyn
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES